Punch & Associates Investment Management Inc. Has $4.22 Million Holdings in Viemed Healthcare, Inc. $VMD

Key Points

• Punch & Associates Investment Management Inc. has reduced its stake in Viemed Healthcare by 31.4%, selling 265,651 shares to hold a total of 580,000 shares valued at approximately $4.22 million.
• Insiders, including Director Nitin Kaushal, have also been selling shares, with the company experiencing a total of 97,922 shares worth about $703,886 sold in the last ninety days.
• Viemed Healthcare reported earnings of $0.08 per share in its latest quarter, meeting analysts' expectations, with revenues of $63.06 million slightly below consensus estimates.

Punch & Associates Investment Management Inc. decreased its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 31.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 580,000 shares of the company's stock after selling 265,651 shares during the quarter. Punch & Associates Investment Management Inc. owned about 1.47% of Viemed Healthcare worth $4,222,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of VMD. Wells Fargo & Company MN boosted its stake in Viemed Healthcare by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 16,024 shares of the company's stock worth $129,000 after acquiring an additional 5,461 shares during the last quarter. Barclays PLC raised its holdings in Viemed Healthcare by 9.7% during the 4th quarter. Barclays PLC now owns 58,635 shares of the company's stock worth $470,000 after buying an additional 5,196 shares during the period. Hsbc Holdings PLC acquired a new stake in Viemed Healthcare during the 4th quarter worth approximately $108,000. Price T Rowe Associates Inc. MD raised its holdings in Viemed Healthcare by 18.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock worth $105,000 after buying an additional 1,997 shares during the period. Finally, Northern Trust Corp raised its holdings in Viemed Healthcare by 1.8% during the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after buying an additional 5,090 shares during the period. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Stock Down 1.5%

VMD stock traded down $0.11 during mid-day trading on Friday, hitting $6.82. 226,288 shares of the company were exchanged, compared to its average volume of 180,046. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.37 and a current ratio of 1.48. The firm has a market cap of $264.35 million, a P/E ratio of 20.04 and a beta of 1.38. The firm's 50 day simple moving average is $6.78 and its 200 day simple moving average is $6.91. Viemed Healthcare, Inc. has a 1-year low of $5.93 and a 1-year high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, hitting the consensus estimate of $0.08. The firm had revenue of $63.06 million for the quarter, compared to the consensus estimate of $63.50 million. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%.

Insiders Place Their Bets

In other Viemed Healthcare news, Director Nitin Kaushal sold 34,100 shares of the firm's stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $7.01, for a total transaction of $239,041.00. Following the sale, the director directly owned 126,843 shares in the company, valued at approximately $889,169.43. This trade represents a 21.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, President Michael Moore sold 50,090 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.33, for a total transaction of $367,159.70. Following the sale, the president owned 126,343 shares in the company, valued at $926,094.19. This trade represents a 28.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 97,922 shares of company stock worth $703,886. Company insiders own 20.00% of the company's stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.